The 4th International Workshop on Acute Leukemias (iwAL) 2022 took place in Nice, France, and brought together leading experts in the field as they discussed several topics. In this podcast series, you will hear the latest updates in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) and gain an insight into the sessions that took place at this year’s meeting.
The first session from iwAL focused on the standard of care in AML in 2022. In this podcast, Mark Levis, MD, PhD, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, Eunice Wang, MD, Roswell Park Comprehensive Cancer Center, Buffalo, NY, Jessica Altman, MD, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, and Charles Craddock, CBE, FRCP, FRCPath, DPhil, University of Birmingham, Birmingham, UK, discuss and debate the current standard of care in AML in 2022, commenting on the role of transplantation and novel agents, as well as treatment approaches for relapsed FLT3-mutated disease.
The post iwAL 2022 Session I: the standard of care in AML in 2022 appeared first on VJHemOnc.
